The Victorian Lung Cancer Registry Pilot: Improving the Quality of Lung Cancer Care Through the Use of a Disease Quality Registry

[11] Barton MB(2001)ESMO Minimum Clinical Recommendations for diagnosis treatment and follow-up of non-small-cell lung cancer (NSCLC) Ann Oncol 12 1049-1064

[12] Yu XQ(2007)Standards, Options et Recommandations pour le traitement peri-operatoire des patients atteints d’un cancer bronchique non a petites cellules resecable d’emblee, operables (mise a jour) (Standards, Options and Recommendations (SOR) for the perioperative treatment of patients with resectable non-small cell lung cancer.) Rev Mal Respir 24 1049-6266

[13] O’Connell DL(2009)American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer J Clin Oncol 27 6251-43

[14] Gibberd RW(2010)American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer J Oncol Pract 6 39-373

[15] Armstrong BK(2002)ERS/ATS statement on interventional pulmonology. European Respiratory Society/American Thoracic Society Eur Respir J 19 356-41

[16] Hall S(2009)ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) Eur Respir J 34 17-184

[17] Holman CD(2009)The European Respiratory Society and European Society of Thoracic Surgeons clinical guidelines for evaluating fitness for radical treatment (surgery and chemoradiotherapy) in patients with lung cancer Eur J Cardiothorac Surg 36 181-v115

[18] Sheiner H(2010)Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 21 v103-8

[19] Hendrie D(2007)ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer Eur J Cardiothorac Surg 32 1-i29

[20] Cunningham J(2007)UK waiting time targets in lung cancer treatment: are they achievable? Results of a prospective tracking study J Cardiothorac Surg 2 5-503S

[11] Barton MB(2001)ESMO Minimum Clinical Recommendations for diagnosis treatment and follow-up of non-small-cell lung cancer (NSCLC) Ann Oncol 12 1049-1064

[12] Yu XQ(2007)Standards, Options et Recommandations pour le traitement peri-operatoire des patients atteints d’un cancer bronchique non a petites cellules resecable d’emblee, operables (mise a jour) (Standards, Options and Recommendations (SOR) for the perioperative treatment of patients with resectable non-small cell lung cancer.) Rev Mal Respir 24 1049-6266

[13] O’Connell DL(2009)American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer J Clin Oncol 27 6251-43

[14] Gibberd RW(2010)American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer J Oncol Pract 6 39-373

[15] Armstrong BK(2002)ERS/ATS statement on interventional pulmonology. European Respiratory Society/American Thoracic Society Eur Respir J 19 356-41

[16] Hall S(2009)ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) Eur Respir J 34 17-184

[17] Holman CD(2009)The European Respiratory Society and European Society of Thoracic Surgeons clinical guidelines for evaluating fitness for radical treatment (surgery and chemoradiotherapy) in patients with lung cancer Eur J Cardiothorac Surg 36 181-v115

[18] Sheiner H(2010)Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 21 v103-8

[19] Hendrie D(2007)ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer Eur J Cardiothorac Surg 32 1-i29

[20] Cunningham J(2007)UK waiting time targets in lung cancer treatment: are they achievable? Results of a prospective tracking study J Cardiothorac Surg 2 5-503S